Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
58,272,553
-
Total 13F shares
-
30,124,596
-
Share change
-
+2,116,349
-
Total reported value
-
$3,347,682,014
-
Put/Call ratio
-
131%
-
Price per share
-
$111.14
-
Number of holders
-
159
-
Value change
-
+$244,304,306
-
Number of buys
-
97
-
Number of sells
-
70
Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common stock, par value $0.0001 per share (AGIO) as of Q2 2015
As of 30 Jun 2015,
AGIOS PHARMACEUTICALS, INC. - Common stock, par value $0.0001 per share (AGIO) was held by
159 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,124,596 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Capital World Investors, BB BIOTECH AG, Flagship Ventures 2007 General Partner LLC, VANGUARD GROUP INC, Capital International Investors, FIRST TRUST ADVISORS LP, CAPITAL GUARDIAN TRUST CO, and BlackRock Fund Advisors.
This page lists
159
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.